An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.
about
Pentasaccharides for the treatment of deep vein thrombosisHeparin versus placebo for non-ST elevation acute coronary syndromesUnfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patientsRates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar.HITlights: a career perspective on heparin-induced thrombocytopeniaThrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemiaMassive Pulmonary Embolism in a Patient with Heparin Induced Thrombocytopenia: Successful Treatment with Dabigatran.Linking laboratory and medication data: new opportunities for pharmacoepidemiological research.Pharmacoeconomics of low-molecular-weight heparins: limitations of studies comparing them to unfractionated heparin.New developments in diagnosis and treatment of heparin-induced thrombocytopenia.Diagnosis and management of heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia in a renal transplant recipient.Fondaparinux: a potential new therapy for HIT.Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparinArgatroban, a direct thrombin inhibitor for heparin-induced thrombocytopaenia: present and future perspectives.Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.Safety and efficacy of danaparoid (Orgaran) use in children.Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.The management of heparin-induced thrombocytopenia.Intraoperative infusion of epoprostenol sodium for patients with heparin-induced thrombocytopenia undergoing cardiac surgery.Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery?Current concepts review: venous thromboembolic disease in foot and ankle surgery.Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass.Current concepts review: heparin-induced thrombocytopenia.Review: recent advances in argatroban-warfarin transition in patients with heparin-induced thrombocytopenia.Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.Thrombocytopenia following percutaneous coronary intervention.Complications related to deep venous thrombosis prophylaxis in trauma: a systematic review of the literature.Drug-induced thrombocytopenia for the hospitalist physician with a focus on heparin-induced thrombocytopenia.Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.Fondaparinux: does it cause HIT? Can it treat HIT?Heparin-induced thrombocytopenia: present and future.A colorimetric, metabolic dye reduction assay detects highly activated platelets: application in the diagnosis of heparin-induced thrombocytopenia.HIT paradigms and paradoxes.Natural language processor as a tool to assess heparin induced thrombocytopenia awareness.A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Management of heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia (HIT II) in liver transplant recipients: a retrospective multivariate analysis of prognostic factors.
P2860
Q24186811-959C0151-540F-41AB-A505-095107B744D8Q24193744-3D3ED83B-7014-43E9-98B2-56C37D4DBB04Q24200589-C2A76823-F3A7-4FA1-AD80-8A99C83D0CF4Q24795717-91B0B935-3513-41F0-9E69-2C2143D94B49Q26828351-1E599716-D02C-4D2A-BB7E-E0A53BD31317Q28213633-BEDCEA72-9134-46B7-A89F-4BE54189B72BQ33166993-E6ED2807-299E-4C64-BE00-637530A8AB1CQ33270070-239DB06B-4B50-484E-B0FA-36EEF2F21A6FQ33362274-5359480B-BDB3-4D39-90B5-D797359E0B1FQ33364828-D816B6D1-3D3C-44E3-8A8E-064D412EA668Q33365985-4152E33D-E910-4CBE-91AF-F4FCBBD201D2Q33366262-B6CC6F77-47E8-46E4-A43A-D8BC989FC618Q33367708-846DEDE5-68BF-4858-9B3C-4004023241EFQ33367978-5FDEA0F7-CEF1-4228-BE9D-E689B8652414Q33369690-712DCD80-E03D-4913-886C-4F9F50200006Q33370227-62845FB5-FB03-4F3C-8166-3A2350E3B158Q33370615-42098546-1450-47FD-94DF-2F8AB058D419Q33370638-A9591849-9188-4B32-B3AA-858F93DC924DQ33371013-416C334E-6E22-45E0-B093-5ED92566BB45Q33372648-D895658F-5495-4F14-86C0-F038F239E576Q33372749-1674F83C-A822-412F-95B2-7360202EA392Q33376013-F2F45D99-3AD8-45E2-8152-A26E93B72F32Q33377443-9360627E-85D6-41E8-95E6-C3640757C18AQ33377839-0E7EEB0F-AD6F-4834-98D6-F2C969FFC858Q33382108-D0493C29-F09C-4B02-A93B-FDBAE90D1D79Q33382275-B0909D8C-D1F0-4C78-858C-5260397DD4BDQ33385883-8E047A44-98F0-4132-8FD4-4D43D49AE229Q33387648-A4FBCB9B-826B-47AC-8E42-934C886164E7Q33388490-5F9DE3C4-66F6-41F7-B814-4D08E91711DAQ33389558-1E78D74F-5214-4967-B6F0-5C895C7734D4Q33392854-EBA3A582-4197-4561-AACE-6B706BE5F24BQ33392864-4DBA245D-884E-44C3-B577-ABC607EDA2B2Q33394188-65DD706C-F7F4-4C11-98F8-85EA1398D1E4Q33396138-1D919124-E124-43DA-9674-84C52DA8E960Q33396313-65B5E8EA-FB5F-4DA1-9737-40860D6083BCQ33396823-F0A19BFA-6E57-4999-972A-A4487ED2F154Q33398776-5A0C4718-7148-4EB7-8045-A1F1C605350DQ33399580-3AF1AF4D-506E-447C-8C99-B4C1C858B9CCQ33400573-072180E6-D351-4CFF-ABD6-77A23289BA3BQ33401025-8C0444A4-72F0-4B05-AFA0-84D8C844EB1D
P2860
An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
An improved definition of immu ...... operative orthopedic patients.
@ast
An improved definition of immu ...... operative orthopedic patients.
@en
type
label
An improved definition of immu ...... operative orthopedic patients.
@ast
An improved definition of immu ...... operative orthopedic patients.
@en
prefLabel
An improved definition of immu ...... operative orthopedic patients.
@ast
An improved definition of immu ...... operative orthopedic patients.
@en
P2093
P1476
An improved definition of immu ...... operative orthopedic patients.
@en
P2093
Jack Hirsh
John G Kelton
Robin S Roberts
P304
P356
10.1001/ARCHINTE.163.20.2518
P407
P577
2003-11-01T00:00:00Z